WOW, BIG NEWS!!!
Dexcom Is in Talks to Acquire Device Firm Insulet was reported by Ed Hammond and Michelle F. Davis for Yahoo.com/Finance, 23 May 2022.
Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in diabetes devices, according to people with knowledge of the matter. Insulet rose as much as 16% in after-market trading on the news.
Talks between the companies are ongoing and an agreement could be reached in the coming weeks, said the people, who asked not to be identified because the information is private. Discussions could still be delayed or fall apart, the people said.
Read more: Dexcom Is in Talks to Acquire Device Firm Insulet
Dexcom cash on hand.
DexCom cash on hand for the quarter ending March 31, 2022 was $2.688B, a 2.11% increase year-over-year.
When a company is awash in cash it has to be used for something. Why not buy the third-largest insulin delivery system in the US? I mean why not.
Insulet support is stellar. Will that change now? Kind of scary.